Canada House Wellness Group, a fully integrated medical cannabis company, is pleased to announce that its wholly owned subsidiary, Abba Medix Corp. has surpassed 900 active medical patient registrations. Abba has experienced accelerated patient growth over the past 6 months with active medical patient registrations growing by more than 50% since January 2021, from fewer than 600 to over 900 today. Over 60% of Abba patients are Veterans, a core demographic that Abba specializes in helping through the provision of top-quality cannabis products and services.
The achievement of this milestone follows Canada House’s recent acquisition of Margaree Health Group Inc. and Abba’s recent exclusively medical supply agreement with Montréal Cannabis Médical Inc.’s (“MTL Cannabis“). In addition to anticipated growth from the continuous buildout of Abba’s product portfolio, Canada House’s acquisition of Margaree has the potential to add additional growth to Abba through the migration of patients as they renew their medical documents over the next 6 to 12 months.
“We previously announced our commitment to offering a well-rounded and curated assortment of our own and third-party LP products to its medical patient base and we have followed through on this commitment. Strong growth follows the creation of a great portfolio of medical products and a commitment to superior service,” commented Chris Churchill-Smith, CEO of Canada House. “I am extremely proud of the entire Canada House team and the growth we have experienced. We will continue to add to Abba’s veteran-oriented portfolio to further fuel growth over the months and years ahead.
For further details on CHC’s acquisition of Margaree and Abba’s exclusive Agreement with MTL Cannabis, please refer to the Company’s press releases dated May 27 and June 14, 2021, available on SEDAR at www.sedar.com.
About Canada House Wellness Group
Canada House Wellness Group is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; IsoCanMed Inc., a Licensed Producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility employing state-of-the-art vertical, aeroponic production methodologies; Canada House Clinics Inc., with clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis. Please visit www.canadahouse.ca or the Company’s public filings at www.sedar.com.